- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/42 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire viraux
Détention brevets de la classe A61K 39/42
Brevets de cette classe: 1889
Historique des publications depuis 10 ans
|
119
|
88
|
94
|
94
|
122
|
171
|
194
|
158
|
126
|
35
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Rockefeller University | 567 |
43 |
| Vanderbilt University | 1894 |
38 |
| Duke University | 3063 |
33 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2839 |
33 |
| Humabs Biomed SA | 122 |
30 |
| Albert Einstein College of Medicine, Inc. | 575 |
22 |
| Regeneron Pharmaceuticals, Inc. | 4238 |
22 |
| The Scripps Research Institute | 1346 |
21 |
| California Institute of Technology | 3973 |
20 |
| The Trustees of the University of Pennsylvania | 4311 |
20 |
| The Regents of the University of California | 19859 |
16 |
| Visterra, Inc. | 130 |
16 |
| International AIDS Vaccine Initiative | 89 |
15 |
| Xiamen University | 533 |
15 |
| Temasek Life Sciences Laboratory Limited | 137 |
14 |
| The University of Chicago | 1392 |
14 |
| Institute of Microbiology, Chinese Academy of Sciences | 117 |
13 |
| Mapp Biopharmaceutical, Inc. | 20 |
13 |
| Academia Sinica | 937 |
12 |
| Adimab, LLC | 141 |
12 |
| Autres propriétaires | 1467 |